These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 7701916)
21. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI]. Tóth J; Szücs FZ; Benkö K; Maródi L Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging. Laudemann K; Moos L; Mengel E; Lollert A; Hoffmann C; Brixius-Huth M; Wagner D; Düber C; Staatz G Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653 [TBL] [Abstract][Full Text] [Related]
23. Organ volume by computed tomography correlates with longitudinal axis on ultrasound in patients with Gaucher disease. Elstein D; Tiomkin M; Hadas-Halpern I; Zimran A Ultrasound Q; 2011 Dec; 27(4):225-8. PubMed ID: 22124387 [TBL] [Abstract][Full Text] [Related]
25. Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease? A review of the literature. Mikosch P; Kohlfürst S; Gallowitsch HJ; Kresnik E; Lind P; Mehta AB; Hughes DA Nuklearmedizin; 2008; 47(6):239-47. PubMed ID: 19057797 [TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance imaging assessment of sacroiliac joint involvement in Gaucher's disease. Bisagni-Faure A; Dupont AM; Chazerain P; Job-Deslandre C; Chevrot A; Menkès CJ J Rheumatol; 1992 Dec; 19(12):1984-7. PubMed ID: 1294753 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of Bone Marrow Infiltration in Non-Neuropathic Gaucher Disease Patients with Use of Whole-Body MRI--A Retrospective Data Analysis. Laudemann K; Moos L; Mengel KE; Lollert A; Reinke J; Brixius-Huth M; Wagner D; Düber C; Staatz G Rofo; 2015 Dec; 187(12):1093-8. PubMed ID: 26200566 [TBL] [Abstract][Full Text] [Related]
29. [Gaucher disease: clinical manifestations of 6 cases]. Mora P; Arnalich F; Fuentes E; Barbado J; del Rey R; Vázquez JJ Med Clin (Barc); 1985 Dec; 85(20):819-22. PubMed ID: 4087966 [No Abstract] [Full Text] [Related]
30. Improving the accuracy of MRI spleen and liver volume measurements: a phase III Gaucher disease clinical trial setting as a model. Bracoud L; Ahmad H; Brill-Almon E; Chertkoff R Blood Cells Mol Dis; 2011 Jan; 46(1):47-52. PubMed ID: 21084202 [TBL] [Abstract][Full Text] [Related]
31. Imaging and quantifying skeletal involvement in Gaucher disease. Maas M; Poll LW; Terk MR Br J Radiol; 2002; 75 Suppl 1():A13-24. PubMed ID: 12036829 [TBL] [Abstract][Full Text] [Related]
33. LIver abnormalities in patients with Gaucher's disease. James SP; Stromeyer FW; Chang C; Barranger JA Gastroenterology; 1981 Jan; 80(1):126-33. PubMed ID: 7450398 [TBL] [Abstract][Full Text] [Related]
34. The pathology of Gaucher disease. Lee RE Prog Clin Biol Res; 1982; 95():177-217. PubMed ID: 7122634 [TBL] [Abstract][Full Text] [Related]
35. [Present status of imaging diagnosis in type I Gaucher's disease]. Roca Espiau M; Mota Martínez J Sangre (Barc); 1997 Jun; 42(3):155-7. PubMed ID: 9381254 [No Abstract] [Full Text] [Related]
36. [Study of Gaucher's cells by the means of electron microscopy]. Neimann N; Grignon G; Gentin G; Guedenet JC; Vidailhet M Ann Pediatr (Paris); 1968 Oct; 15(10):625-31. PubMed ID: 5716718 [No Abstract] [Full Text] [Related]
37. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging--initial experience. Maas M; van Kuijk C; Stoker J; Hollak CE; Akkerman EM; Aerts JF; den Heeten GJ Radiology; 2003 Nov; 229(2):554-61. PubMed ID: 14526090 [TBL] [Abstract][Full Text] [Related]
38. Image of the month. Hepatic Gaucheroma mimicking focal nodular hyperplasia. Poll LW; Vom Dahl S Hepatology; 2009 Sep; 50(3):985-6. PubMed ID: 19714719 [No Abstract] [Full Text] [Related]
39. The clinical course of treated and untreated Gaucher disease. A study of 45 patients. Beutler E; Demina A; Laubscher K; Garver P; Gelbart T; Balicki D; Vaughan L Blood Cells Mol Dis; 1995; 21(2):86-108. PubMed ID: 8846048 [TBL] [Abstract][Full Text] [Related]
40. Spontaneous regression of disease manifestations can occur in type 1 Gaucher disease; results of a retrospective cohort study. Boomsma JM; van Dussen L; Wiersma MG; Groener JE; Aerts JM; Maas M; Hollak CE Blood Cells Mol Dis; 2010 Mar; 44(3):181-7. PubMed ID: 20074983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]